VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells-Reference-Cited by-同舟云学术

VMY-1-103 is a novel CDK inhibitor that disrupts chromosome organization and delays metaphase progression in medulloblastoma cells

Published:2011-11 Issue:9 Volume:12 Page:818-826
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Ringer Lymor,Sirajuddin Paul,Heckler Mary,Ghosh Anup,Suprynowicz Frank,Yenugonda Venkata M.,Brown Milton L.,Toretsky Jeffrey A.,Üren Aykut,Lee YiChien,MacDonald Tobey J.,Rodriguez Olga,Glazer Robert I.,Schlegel Richard,Albanese Chris

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.12.9.17682

Reference33 articles.

1. Development and cancer of the cerebellum

2. Cognitive Consequences of the Treatment of Medulloblastoma Among Children

3. Medulloblastoma: advances and challenges

4. Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features

5. Medulloblastoma Comprises Four Distinct Molecular Variants

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expansion of human amniotic epithelial cells using condition cell reprogramming technology;Human Cell;2022-12-31

2. Identification of hub genes and potential molecular mechanisms in medulloblastoma by integrated bioinformatics analysis;2022-09-22

3. Identification of Potential Key Genes and Molecular Mechanisms of Medulloblastoma Based on Integrated Bioinformatics Approach;BioMed Research International;2022-01-04

4. Regulation of Chemosensitivity in Human Medulloblastoma Cells by p53 and the PI3 Kinase Signaling Pathway;Molecular Cancer Research;2021-10-11

5. Identification of Core Genes and Pathways in Medulloblastoma by Integrated Bioinformatics Analysis;Journal of Molecular Neuroscience;2020-06-13